18 Nov 2024
// PR NEWSWIRE
30 Oct 2024
// PRESS RELEASE
29 Oct 2024
// PR NEWSWIRE
Latest Content by PharmaCompass
01 2ACITRETIN
02 3ASENAPINE MALEATE
03 2ASPIRIN; BUTALBITAL; CAFFEINE
04 1ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
05 2Atropine
06 1BEZAFIBRATE
07 2BRIMONIDINE TARTRATE
08 9Bimatoprost
09 1Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride
10 3Brimonidine Tartrate
11 2CHLORAMPHENICOL
12 1CHLORAMPHENICOL; PREDNISOLONE
13 1CROMOLYN SODIUM
14 1CYCLOSPORINE
15 1Clostridium botulinum neurotoxin typ A
16 3Clostridium botulinum neurotoxin type A
17 1Cyclopentolate
18 1DEXAMETHASONE
19 2DICYCLOMINE HYDROCHLORIDE
20 3DILTIAZEM HYDROCHLORIDE
21 1DIPIVEFRIN HYDROCHLORIDE
22 1Deoxycholic Acid
23 4Dexamethasone
24 1EPINASTINE HYDROCHLORIDE
25 1ESTRADIOL
26 4ETHINYL ESTRADIOL; NORETHINDRONE
27 1ETHOXZOLAMIDE
28 1Epinastine
29 1FERRIC OXYHYDROXIDE
30 4FLUOCINOLONE ACETONIDE
31 1FLUOROMETHOLONE
32 1FLUOROMETHOLONE; SULFACETAMIDE SODIUM
33 1FLURBIPROFEN SODIUM
34 1Flurbiprofen
35 1GATIFLOXACIN
36 1GENTAMICIN SULFATE
37 2GENTAMICIN SULFATE; PREDNISOLONE ACETATE
38 5HYDROCORTISONE
39 2HYDROXYPROGESTERONE CAPROATE
40 1IDOXURIDINE
41 1KETOROLAC TROMETHAMINE
42 1Ketorolac Tromethamine
43 2LEVOBUNOLOL HYDROCHLORIDE
44 6LIOTRIX (T4;T3)
45 3Levobunolol
46 2Levobunolol hydrochloride
47 2Linaclotide
48 1MEDRYSONE
49 1MEMANTINE HYDROCHLORIDE
50 12MORPHINE SULFATE
51 1NAPHAZOLINE HYDROCHLORIDE
52 4NEBIVOLOL HYDROCHLORIDE
53 1NEDOCROMIL SODIUM
54 1NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
55 1OFLOXACIN
56 2OXYBUTYNIN
57 2Ofloxacin
58 5OnabotulinumtoxinA
59 1PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
60 1PODOFILOX
61 1POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
62 2PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
63 2PROGESTERONE
64 1PROPARACAINE HYDROCHLORIDE
65 2Pilocarpine
66 1Progesterone
67 1SELENIUM SULFIDE
68 3SULFACETAMIDE SODIUM
69 3Several substances refer to content
70 5TAZAROTENE
71 2TRETINOIN
72 1TRIAMCINOLONE ACETONIDE
73 3TRIMEPRAZINE TARTRATE
74 2TROSPIUM CHLORIDE
75 2Tazarotene
76 6Timolol
77 2Timolol; Bimatoprost
78 1Timolol; Brimonidine
79 2URSODIOL
80 3bimatoprost
81 1brimonidine tartrate
82 2carmellose
83 1dexametason
84 1epinastine hydrochloride
85 1pirenoxine
01 100ALLERGAN
02 14ALLERGAN HERBERT
03 3ALLERGAN INC
04 1ALLERGAN PHARMACEUT.INTERN.LTD
05 8ALLERGAN PHARMACEUTIC.IRELAND
06 14ALLERGAN SpA
07 4Allergan Pharmaceuticals (Pty) Ltd
08 12Allergan Pharmaceuticals Ireland
09 2Allergan Solvay International Limited
10 2Allergan Solvay International Ltd. (1)
11 15Allergan Solvay Ireland Ltd
12 3Allergan, Inc. Waco
01 2AEROSOL;TOPICAL
02 1Bimatoprost 0,3Mg/Ml 0.4 Ml 30Units Solution Ophthalmic Use
03 1Bimatoprost 0,3Mg/Ml 3Ml Solution Ophthalmic Use
04 1Bimatoprost 0.1Mg/Ml 3Ml Solution Ophthalmic Use
05 1Bismuth Oxide+Metronidazole+Tetracycline Hydrochloride 140+125+125Mg 120 Unita' Oral Use
06 1Brimonidine 0.2% 5Ml Solution Ophthalmic Use
07 2CAPSULE
08 17CAPSULE, EXTENDED RELEASE;ORAL
09 3CAPSULE;ORAL
10 7CREAM;TOPICAL
11 1CREAM;VAGINAL
12 2Capsule, hard
13 1Dexamethasone 700Mcg 1 Units Use Intravitreale
14 1EMULSION; OPHTHALMIC
15 6EYE DROPS, SOLUTION
16 4EYE DROPS, SOLUTION IN SINGLE-DOSE CONTAINERS
17 14Eye drops, resolution
18 1FILM, EXTENDED RELEASE;TRANSDERMAL
19 2GEL
20 1GEL, METERED;TRANSDERMAL
21 5GEL;TOPICAL
22 2GEL;VAGINAL
23 3INJECTABLE;INJECTION
24 1INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
25 1INTRAVITREALT IMPLANTAT I APPLIKATOR
26 1Injection fluid, resolution
27 1Intrauterine Posts
28 1Intravitrealt implant in applicator
29 1LOTION/SHAMPOO;TOPICAL
30 1Levobunolol 0.5% 0.4 Ml 60 Units Solution Ophthalmic Use
31 1Levobunolol 0.5% 5Ml Solution Ophthalmic Use
32 6OINTMENT;OPHTHALMIC
33 2OINTMENT;TOPICAL
34 2OPD
35 3POWDER FOR SOLUTION FOR INJECTION
36 1PULVER TILL INJEKTIONSVÄTSKA, LÖSNING
37 21SOLUTION/DROPS;OPHTHALMIC
38 1SOLUTION;ORAL
39 2SOLUTION;TOPICAL
40 3SUSPENSION/DROPS;OPHTHALMIC
41 2SUSPENSION;OPHTHALMIC
42 1SYRUP;ORAL
43 1TABLET (EXTENDED-RELEASE)
44 17TABLET;ORAL
45 2TABLET;ORAL-21
46 2TABLET;ORAL-28
47 3TABLET;SUBLINGUAL
48 1Timolol+Bimatoprost 300Mcg/Ml+5Mg/Ml 30 Joined' Solution Ophthalmic Use
49 1Timolol+Bimatoprost 900Mcg+15Mg Solution Ophthalmic Use
50 1Timolol+Bromonidine 0.2%+0.5% 5Ml Solution Ophthalmic Use
51 5VIAL; SINGLE-USE
52 14Blank
01 2-
02 20.01%
03 10.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
04 10.0125MG;0.0031MG
05 30.025%
06 10.025MG;0.0063MG
07 10.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
08 20.035MG;0.5MG
09 20.035MG;1MG
10 10.0375%
11 30.05%
12 10.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
13 10.05MG;0.0125MG
14 10.075%
15 10.1 MG / ML
16 20.1 mg/ml
17 60.1%
18 10.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
19 10.1%;10%
20 10.12%;0.1%
21 10.15MG;0.0375MG
22 10.1MG;0.025MG
23 10.2% (2 MG / ML)
24 10.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
25 20.2%;10%
26 10.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
27 10.25MG;0.0625MG
28 20.3 MG / ML
29 20.3 MG / ML + 5
30 40.3 mg/ml
31 40.3 mg/ml/5 mg/ml
32 20.3%
33 10.5 MG / ML
34 60.5%
35 10.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
36 51%
37 11%;0.5%
38 110 mg/ml
39 210%
40 110,000 UNITS/ML;EQ 1MG BASE/ML
41 1100 ALLERGAN
42 2100 UNITS/VIAL
43 1100MG
44 210MG
45 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
46 1120 cps 140 mg + 125 mg + 125 mg
47 1120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
48 1125MG
49 1125MG/ML
50 1130MG
51 1150MG
52 1180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
53 11mg/g
54 12 MG / ML + 5 MG / ML
55 22 mg/ml
56 22 mg/ml/5 mg/ml
57 12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
58 22.5%
59 120 mcg/24 hours
60 1200 ALLERGAN
61 1200 UNITS/VIAL
62 1200MG
63 120MG
64 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
65 1240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
66 1250MG
67 1250MG/ML
68 125MG
69 2290 mcg
70 12MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
71 13%
72 13.9MG/24HR
73 130%
74 130MG
75 2325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
76 1325MG;50MG;40MG;30MG
77 14
78 14%
79 14% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
80 140 Monod Coll 0.4 Ml 0.03%
81 1400MG
82 140MG
83 150 ALLERGAN UNITS
84 250 UNITS/VIAL
85 1500MG
86 150MG
87 35mg/ml
88 160MG
89 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
90 1700 MIKROGRAM
91 1700 mcg
92 170MG
93 18%
94 180MG
95 18MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
96 1Coll 10 Ml 0.3%
97 1Coll 10 Ml 0.5%
98 2Coll 10 Ml 1%
99 1Coll 10 Ml 2%
100 1Coll 3 Ml 0.2%
101 1Coll 3 Ml 1%
102 1Coll 5 Ml 0,5 Mg/Ml
103 1Coll 5 Ml 0.1%
104 1Coll 5 Ml 0.5%
105 1Coll Bottle Groun 0.005% + Plug Solv 7 Ml
106 1EQ 0.3% BASE
107 1EQ 0.3% BASE;0.6%
108 1EQ 0.3% BASE;1%
109 1EQ 0.35% BASE;10,000 UNITS/ML;0.5%
110 1EQ 100MG IRON/2ML (EQ 50MG IRON/ML)
111 2EQ 10MG BASE
112 3EQ 2.5MG BASE
113 1EQ 2.5MG BASE/5ML
114 1EQ 20MG BASE
115 3EQ 5MG BASE
116 1EYE DROPS 3 ML 300 mcg/ml + 5 mg/ml
117 1EYE DROPS 3 ml 0,3 mg/ml
118 1EYE DROPS 3 ml 0. 1 mg/ml
119 1EYE DROPS 5 ml 0.2% + 0.5%
120 1EYE DROPS 5 ml 2 mg/ml
121 1EYE DROPS 5 ml 5 mg/ml
122 1Pom Oftalm 3,5 G 0,3%
123 1Ung Oftalm 3 G 0,2%
124 1collyrium 30 monodose containers 0.4 ml 300 mcg/ml + 5 mg/ml
125 1collyrium 30 monodose vials 0.4 ml 0,3 mg/ml
126 1collyrium 60 monodose vials 0.4 ml 5 mg/ml
127 1intravitreale implant 700 mcg + applicator
01 3Canada
02 25Italy
03 19Norway
04 4South Africa
05 15Sweden
06 112USA
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : SORIATANE
Dosage Strength : 25MG
Packaging : 30
Approval Date :
Application Number : 2070863
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : SORIATANE
Dosage Strength : 10MG
Packaging : 30
Approval Date :
Application Number : 2070847
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2009-08-13
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2009-08-13
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 2.5MG BASE
Packaging :
Approval Date : 2015-03-12
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Fede...
Packaging :
Approval Date : 1986-04-16
Application Number : 17534
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : CAPSULE;ORAL
Brand Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Fede...
Packaging :
Approval Date : 1986-04-16
Application Number : 17534
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Brand Name : FIORINAL W/CODEINE
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 1990-10-26
Application Number : 19429
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Dosage Form :
Brand Name : Atropine Lux
Dosage Strength : Coll 10 Ml 0.5% ...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form :
Brand Name : Atropine Lux
Dosage Strength : Coll 10 Ml 1% ...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
LOOKING FOR A SUPPLIER?